Tarsus Pharmaceuticals (TARS) Treasury Shares (2019 - 2026)

Tarsus Pharmaceuticals' Treasury Shares history runs 8 years deep, the most recent figure standing at $721325.0 for Q1 2026.

• On a quarterly basis, Treasury Shares fell 62.65% year-over-year to $721325.0 in Q1 2026; TTM through Mar 2026 was $721325.0, a 62.65% decrease from a year earlier, with the FY2025 full-year figure at $1.8 million, down 8.3% from the prior year.
• Treasury Shares retreated to $721325.0 in Q1 2026 per TARS's latest filing, from $1.8 million in the prior quarter.
• Across five years, Treasury Shares topped out at $2.0 million in Q1 2024 and bottomed at $551258.0 in Q4 2022.
• The 5-year median for Treasury Shares is $1.7 million (2023), against an average of $1.4 million.
• Across the five-year window, Treasury Shares surged 3095.51% in 2022 and plunged 63.55% in 2025, its largest moves.
• Year by year, Treasury Shares stood at $551258.0 in 2022, then soared by 209.97% to $1.7 million in 2023, then rose by 12.09% to $1.9 million in 2024, then slipped by 8.3% to $1.8 million in 2025, then plunged by 58.93% to $721325.0 in 2026.
• Per Business Quant, the three latest TARS Treasury Shares figures stand at $721325.0 (Q1 2026), $1.8 million (Q4 2025), and $714806.0 (Q3 2025).